Why the study?
Parkinson's disease is a possible risk factor for QTc prolongation, and patients frequently take QTc-prolonging drugs, but the prevalence and influencing risk factors required assessment.
Population
101 patients with Parkinson's disease and a good quality ECG
Authors
Loading...
QTc monitoring may be considered in PD patients on QT-prolonging drugs; leaves open whether prolongation predicts events or warrants routine screening.
QTc prolongation is relatively common in Parkinson's disease patients and is associated with older age, male sex, and the use of QTc-prolonging medications.
Malkiewicz et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: